Lauretta LeVoci
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Renal and related cancers, Liver physiology and pathology, Diabetes, Cardiovascular Risks, and Lipoproteins, MicroRNA in disease regulation, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → MicroRNA‐23b cluster microRNAs regulate transforming growth factor‐beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads†(2009)206 cited
- → Transcriptional profiling implicates TGFβ/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts(2006)63 cited
- → New cell surface markers for murine fetal hepatic stem cells identified through high density complementary DNA microarrays†(2007)45 cited
- → Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein(2012)20 cited
- → Characterization of Anacetrapib Distribution into the Lipid Droplet of Adipose Tissue in Mice and Human Cultured Adipocytes(2018)6 cited
- → Clonal, cultured, murine fetal liver hepatoblasts maintain liver specification in chimeric mice(2007)6 cited